Mesoblast Ltd
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.
Other share classesMEOBF
Q3 2021 vs. Q2 2021
How the institutions holding Mesoblast Ltd changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 50 | 41 | −9 |
| Shares | 3.95M | 3.53M | −421.7K (−10.7%) |
| Value | $28.9M | $21.2M | −$7.69M (−26.6%) |
New holders (3)
Institutions that held Mesoblast Ltd at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 11,000 | $66.0K | 0.00% |
| Wells Fargo & Company | 115 | $1.00K | 0.00% |
| Bell Investment Advisors, Inc | 136 | $1.00K | 0.00% |
Sold out (12)
Institutions that held Mesoblast Ltd at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Susquehanna International Group, LLP | 349,111 | $2.61M |
| Princeton Capital Management LLC | 183,914 | $1.38M |
| State Street Corp | 90,000 | $673.0K |
| Stifel Financial Corp | 86,872 | $650.0K |
| Cowen and Company, LLC | 57,300 | $429.0K |
| Group One Trading, L.P. | 22,038 | $165.0K |
| Virtu Financial LLC | 17,321 | $130.0K |
| Advisor Resource Council | 10,000 | $75.0K |
| Moors & Cabot, Inc. | 45,131 | $67.0K |
| Tower Research Capital LLC (TRC) | 4,867 | $36.0K |
| Citigroup Inc | 1,000 | $7.00K |
| Federation des caisses Desjardins du Quebec | 250 | $1.87K |